Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation

Int Immunopharmacol. 2014 Oct;22(2):409-13. doi: 10.1016/j.intimp.2014.07.026. Epub 2014 Aug 1.

Abstract

Lipopolysaccharide (LPS), also called endotoxin, is the important pathogen of acute lung injury (ALI), which is a clinical syndrome that still lacks effective therapeutic medicine. Rutin belongs to vitamin P and possesses various beneficial effects. In this study, we investigate the potential protective effects and the mechanisms of rutin on LPS-induced ALI. Pre-administration with rutin inhibited LPS-induced arterial blood gas exchange and neutrophils infiltration in the lungs. LPS-induced expression of macrophage inflammatory protein (MIP)-2 and activation of matrix metalloproteinase (MMP)-9 were suppressed by rutin. In addition, the inhibitory concentration of rutin on phosphorylation of Akt was similar as MIP-2 expression and MMP-9 activation. In conclusion, rutin is a potential protective agent for ALI via suppressing the blood gas exchange and neutrophil infiltration. The mechanism of rutin is down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation.

Keywords: Acute lung injury; Akt; LPS; MIP-2; MMP-9; Rutin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / metabolism*
  • Animals
  • Bronchoalveolar Lavage Fluid / chemistry
  • Chemokine CXCL2 / metabolism*
  • Down-Regulation
  • Lipopolysaccharides
  • Lung / drug effects
  • Lung / immunology
  • Lung / metabolism
  • Lung / pathology
  • Matrix Metalloproteinase 9 / metabolism*
  • Mice
  • Neutrophil Infiltration / drug effects
  • Phosphorylation
  • Protective Agents / pharmacology*
  • Protective Agents / therapeutic use
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rutin / pharmacology*
  • Rutin / therapeutic use

Substances

  • Chemokine CXCL2
  • Cxcl2 protein, mouse
  • Lipopolysaccharides
  • Protective Agents
  • Rutin
  • Proto-Oncogene Proteins c-akt
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse